EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects

Virendra Rambiritch, Poobalan Naidoo, Breminand Maharaj, Goonaseelan Pillai

Clinical Pharmacology: Advances and Applications · 2016

DOI: 10.2147/cpaa.s102676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2016. Verfasst von Virendra Rambiritch und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of KwaZulu-Natal, Durban. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

NONMEM modelcompartmentalglibenclamidepharmacokineticstype 2 diabetes mellitus

Autor:innen und Institutionen

  • University of KwaZulu-Natal, Durban.
  • Department of Internal Medicine, RK Khan Regional Hospital, Chatsworth, South Africa.
  • Novartis Pharma AG, Basel, Switzerland.

Zitieren

APA

Rambiritch, V., Naidoo, P., Maharaj, B., & Pillai, G. (2016). Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects. Clinical Pharmacology: Advances and Applications. https://doi.org/10.2147/cpaa.s102676

Vancouver

Rambiritch V, Naidoo P, Maharaj B, Pillai G. Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects. Clinical Pharmacology: Advances and Applications. 2016. doi:10.2147/cpaa.s102676

BibTeX
@article{Rambiritch2016,
  author = {Rambiritch, Virendra and Naidoo, Poobalan and Maharaj, Breminand and Pillai, Goonaseelan},
  title = {Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects},
  journal = {Clinical Pharmacology: Advances and Applications},
  year = {2016},
  doi = {10.2147/cpaa.s102676}
}
Kostenlos starten →